Sentiment Trading

ZAI LAB LTD

Is Zai Lab’s Biotech Innovation Enough to Overcome its Troubling Negative P/E Ratio?

Is Zai Lab’s Biotech Innovation Enough to Overcome its Troubling Negative P/E Ratio?

Investors weigh Zai Lab’s biotech innovation against a negative P/E and falling stock price—can its oncology and autoimmune therapies turn the tide?

06/08/2026, 12:42

3 minutes to read

Prepare for Zai Lab's 2026 AGM: Director Re‑elections, KPMG Audit, & Shareholder Resolutions

Prepare for Zai Lab’s 2026 AGM: Director Re‑elections, KPMG Audit, & Shareholder Resolutions

Explore Zai Lab’s 2026 AGM details: director re‑elections, auditor appointments, shareholder resolutions, and its biopharma growth strategy.

17/04/2026, 21:09

3 minutes to read